Virginia Board of Medicine Practitioner Information

Home Icon Home

Search Icon Search

Disclaimer Icon Disclaimers

Links Icon Links

Glossary Icon Glossary

Help Icon Questions


Printer Friendly Version Printer Icon
 

Jamie Kendrick Waselenko, MD

LICENSE # 0101233765
 
Issue Date: 10/23/2002
Expiration Date: 1/31/2026
Status: Current Active


General InformationEducationCertifications & Practice AreaInsuranceHonors & AwardsAcademic Appointments & PublicationsProceedings, Actions & ConvictionsPaid Claims
Unless otherwise indicated, this information has been self-reported and has not been verified by the Board of Medicine.


Academic Appointments
Last Updated 12/14/2023
None Reported
Academic Appointments - Non-US
Last Updated 12/14/2023
None Reported
Publications
(up to ten in the last five years)
Last Updated 12/14/2023
Pentostatin (Nipent) and chlorambucil with GM-CSF support for patients with previously untreated, treated, and fludarabine-refractory B-cell chronic lymphocytic leukemia
Semin Oncol
27 (Suppl 5)
Date: 04 2000

Novel therapies for chronic lymphocytic leukemia in the 21st century
Semin Oncol
Volume: 27
Date: 10 2000

Rituximab administered using a thrice weekly dosing schedule in B-cell chronic lymphocytic leukemia and small lymphocytic lymphoma demonstrates significant activity
J Clin Oncol
Volume: 19
Date: 04 2001

Gemcitabine demonstrates selective in vitro activity in human B-cell chronic lymphocytic leukemia
Leukemia Research
Volume: 25
Date: 06 2001

Carboxyamido-triazole (CAI), a novel static signal transduction inhibitor induces apoptosis in human B-chronic lymphocytic leukemia cells
Leuk Lymphoma
Volume: 42
Date: 09 2001